Conversely, a study by Zhong and colleagues reports that patients diagnosed with HCC in the setting of underlying viral hepatitis B (HBV+) infection exhibit low FABP4 expression in HCC tissue, and that the level of FABP4 expression is associated with tumor size and overall survival. Here, FABP4 is linked to neoplasm.